2-Chloro-5-Nitrothiazole

2-Chloro-5-Nitrothiazole


    • Product Name 2-Chloro-5-Nitrothiazole
    • Alias 2-Chloro-5-nitro-1,3-thiazole
    • Einecs 629-133-4
    • Mininmum Order 25g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    188995

    Chemical Formula C3HClN2O2S
    Molecular Weight 164.57
    Appearance Yellow crystals or powder
    Melting Point 118 - 122 °C
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in some organic solvents like ethanol, chloroform
    Stability Stable under normal conditions, but may react with strong oxidizing agents
    Hazard Harmful if swallowed, inhaled or in contact with skin; irritant to eyes

    As an accredited 2-Chloro-5-Nitrothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 250 - gram bottle of 2 - Chloro - 5 - Nitrothiazole, well - sealed for chemical storage.
    Shipping 2 - Chloro - 5 - Nitrothiazole is shipped in sealed, corrosion - resistant containers. Compliance with hazardous chemical shipping regulations is ensured, with proper labeling indicating its nature for safe transportation.
    Storage 2 - Chloro - 5 - nitrothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and incompatible substances like strong oxidizers. Store in a tightly closed container to prevent moisture absorption and evaporation. Label the storage container clearly to avoid misidentification.
    Application of 2-Chloro-5-Nitrothiazole

    In the manufacture of nitazoxanide and its pharmacopoeial analogues, 2-chloro-5-nitrothiazole serves as the primary heterocyclic building block that defines the activity-conferring 5-nitrothiazol-2-yl pharmacophore. The established industrial route proceeds through sealed-vessel aminolysis in 25% aqueous ammonia at 105–110°C (3.5–4.0 bar) within 316L stainless steel autoclaves, yielding 2-amino-5-nitrothiazole after neutralisation and centrifuge isolation; this intermediate must exhibit an area-normalised purity exceeding 99.7% by HPLC (USP <621>) before acylation with 2-acetoxybenzoyl chloride. Batch records from multi-ton campaigns indicate that exceeding a peak jacket temperature of 112°C during the exothermic aminolysis stage increases the dimeric impurity bis(5-nitrothiazol-2-yl)amine above the 0.10% threshold mandated under the ICH Q3A reporting limit for nitazoxanide drug substance at a daily dose of 1 g. The acylation step is conducted in anhydrous dichloromethane or tetrahydrofuran with triethylamine as a proton scavenger, maintaining an internal temperature below 5°C to suppress ring-dehalogenation side reactions that generate the des-chloro impurity tracked in the USP Nitazoxanide monograph (related compound C, USP reference standard 1463509). Residual solvent profiles must comply with ICH Q3C (R8) limits: dichloromethane not exceeding 600 ppm, tetrahydrofuran capped at 720 ppm, and triethylamine controlled below 320 ppm via GC-headspace analytics calibrated against Class 2 residual solvent standards. Finished nitazoxanide API is micronised to a particle size distribution of D₉₀ ≤ 15 µm (Malvern Mastersizer, wet dispersion) for oral suspension formulations, and final product tablets are tested per USP <2040> for dissolution in pH 6.8 phosphate buffer with a Q value of 80% at 45 minutes. The terminal dosage forms encompass immediate-release 500 mg film-coated tablets, 100 mg/5 mL powder-for-suspension paediatric formulations, and veterinary boluses for ruminants, all of which require absence of mutagenic nitrothiazole-related impurities validated by Ames test (OECD 471) at a limit of detection of 10 µg/plate.

    Halogen-Retentive Suzuki-Miyaura Coupling Sequences for Thiazole-Functionalised Acaricide Lead Structures

    In the synthesis of contact acaricides and piercing-sucking pest insecticides, the C–Cl bond of 2-chloro-5-nitrothiazole is exploited as a cross-coupling handle in palladium-catalysed reactions to construct biaryl or styrenyl architectures while keeping the electron-withdrawing nitro group intact for target-site binding to mitochondrial complex II or nicotinic acetylcholine receptors. A production-scale coupling protocol documented in a 2,000 L glass-lined Hastelloy reactor uses 1.8 mol% Pd(PPh₃)₄ catalyst with 4-substituted phenylboronic acid (1.15 equivalents) in a degassed mixture of toluene:ethanol:water (5:2:1 v/v/v) and a potassium carbonate base loading of 2.5 equivalents at 78–82°C for 18–22 hours. The batch cost structure is dominated by the palladium retention step: filtration through a 0.5 µm sintered-metal candle filter at the end of the reaction reduces catalyst entrainment into the organic phase, and ICP-MS analysis of the crude product must show residual palladium below 20 ppm to meet the procurement specification of generic agrochemical formulators aligned with FAO Specification 548/TC (feb. 2020) for technical-grade active ingredients. Process deviations where the water content exceeds 12% v/v in the initial charge have been directly correlated with a drop in the isolated yield from a baseline of 78% to below 55% due to premature catalyst decomposition through phosphine ligand hydrolysis, a failure mode confirmed by ³¹P NMR monitoring of the spent aqueous layer. Post-coupling reduction of the 5-nitro group using Raney Ni 2800 (slurry in methanol, 4 bar H₂, 50°C) in a loop-reactor configuration produces the corresponding aniline derivative, which is directly employed in the subsequent amidotriazole ring closure to form the pesticidal core. Formulation of the resulting technical-grade acaricide into a 240 g/L suspension concentrate requires wet-milling on a WAB Dyno®-Mill KD 60 with 0.3–0.5 mm yttria-stabilised zirconia beads until the particle size attains a D₉₀ ≤ 3 µm, a critical quality attribute for suspensibility per CIPAC MT 184. The final formulated product is applied in pome fruit and citrus orchards at a spray concentration corresponding to 0.015–0.025% active ingredient, and compliance with the EU residue definition set under Regulation (EC) No 396/2005 requires a Maximal Residue Level validation for the sum of the parent acaricide and its 5-amino-thiazole metabolite.

    Reprocessing of 2-chloro-5-nitrothiazole into heterocyclic disperse azo colorants for polyester and polyamide fibres relies on the sequential reduction-diazotization-coupling pathway that converts the 5-nitro group into a diazonium electrophile while preserving the 2-chloro substituent for its bathochromic and electron-sink effect in the final dye molecule. In a dedicated dye intermediate plant with segregated equipment trains to avoid cross-contamination of pharma-destined batches, the reduction step uses iron powder (100–200 mesh) in dilute hydrochloric acid at pH 1.5–2.0 at 85–90°C inside a rubber-lined 5,000 L reduction vessel; the resulting 2-chloro-5-aminothiazole is isolated as its hydrochloride salt and is used without drying in the downstream diazotization at 0–5°C with stoichiometric sodium nitrite. The coupling component is usually an N,N-dialkylaniline derivative such as N-ethyl-N-cyanoethylaniline, and the ratio of coupling component to diazonium salt is maintained at 1.02:1.00 to avoid the formation of bis-azo side products that would fail the AATCC Test Method 16.3 lightfastness requirement of Grade 4 or higher on 100% polyester twill. The dispersed dye filter cake is standardised to 40% active content with sodium lignosulfonate (60%) and is dried in a Niro spray dryer at an inlet temperature of 180°C; the resulting granular formulation is dosed at 0.5–3.0% on weight of fabric in high-temperature exhaust dyeing machines at 130°C. All colourants placed on the EU textile market require a ZDHC MRSL Level 3 compliance certificate with verification of absence of restricted arylamines as per EN 14362-1:2017, and the 2-chloro-5-nitrothiazole-derived azo dyes are routinely screened for 4-chloroaniline release potential by reductive cleavage test.

    When Electron-Transporting Thiazole Monomers Require a Defined C–Cl Co-Polymerization Handle in Non-Fullerene Acceptor Blends

    For the synthesis of all-polymer and small-molecule acceptors in organic photovoltaics, 2-chloro-5-nitrothiazole functions as a symmetrical-electron-deficient precursor that can be functionalised into a distannyl-thiazole monomer suitable for Stille polycondensation with brominated diketopyrrolopyrrole or isoindigo co-monomers. In a controlled glovebox environment (O₂ < 1 ppm, H₂O < 1 ppm), 2-chloro-5-nitrothiazole is first converted to the 2-tri-n-butylstannyl-5-nitrothiazole derivative by lithiation with LDA at −78°C followed by quenching with tributyltin chloride; this stannylated intermediate must be titrated to a concentration of 0.50 M in anhydrous THF before being fed into the polycondensation reactor loaded with a Pd₂(dba)₃/P(o-tol)₃ catalyst system at a monomer:catalyst ratio of 100:1. Molar mass control is achieved by strict monofunctional impurity profiling: the Stille monomer must contain less than 0.3 mol% of protodestannylated species determined by ¹H NMR end-group analysis, otherwise the resulting polymer batch will exhibit a number-average molecular weight (Mₙ) falling below the 35 kDa cutoff required to form adequate domain sizes in the active layer blend. The polymer work-up involves Soxhlet extraction with methanol (removing oligomers below 5 kDa), acetone (removing residual catalyst), and finally dichlorobenzene to recover the photovoltaic-grade fraction. Device fabrication in a pre-production slot-die coater applies a blend of the thiazole-containing acceptor polymer with the donor polymer PM6 at a weight ratio of 1:1.2, dissolved in chloroform:o-xylene (85:15) with 0.5 vol% 1,8-diiodooctane as a processing additive; the wet film thickness is set to 12 µm to yield a dry active-layer thickness of 110–130 nm after annealing at 100°C for 10 minutes on a hotplate under nitrogen. Photovoltaic performance is characterised according to IEC 60904-1:2020 under a Class AAA AM 1.5G solar simulator at 100 mW/cm², and the power conversion efficiency of the thiazole-containing devices is benchmarked against a PCE₁₀ LBG reference with the requirement that the maximum power point tracking stability over 100 hours remains within 90% of the initial value. The terminal product targeted by downstream module manufacturers is a flexible BIPV panel with an aperture area of 0.6 m², necessitating a module-level accelerated aging test per IEC 61215-2:2021 clause MQT 13 (damp heat, 85°C / 85% RH, 1000 hours).

    In combinatorial synthesis libraries aimed at hit-to-lead progression against kinetoplastid protozoa, 2-chloro-5-nitrothiazole is exploited as a bifunctional scaffold undergoing sequential nucleophilic aromatic substitution under increasingly aggressive conditions to generate a matrix of 2-substituted-5-nitrothiazole analogues. When microwave-assisted parallel synthesis is performed in 10 mL borosilicate vials in a Biotage Initiator+ cavity, the optimal conditions for displacing the 2-chloro leaving group with aliphatic cyclic amines (pyrrolidine, piperidine, morpholine) are found to be 1.2 equivalents of amine in DMF at 120°C for 30 minutes, affording products in 75–92% isolated yield after aqueous workup and flash chromatography on a 40 g silica cartridge with an ethyl acetate:heptane gradient. Competing reduction of the nitro group sets in when secondary amines with strong hydride-donor character (e.g., pyrrolidine) are used in excess beyond 1.5 equivalents at temperatures exceeding 130°C, a side reaction identified by the appearance of an LC-MS signal at m/z M+2 corresponding to the 2-amino-5-nitrothiazole derivative, thus limiting the scope of direct amination in discovery workflows that demand single-component reaction profiles. These nitrothiazole-containing building blocks are subsequently incorporated into high-throughput screening plates, and all dispensing protocols must conform to ANS Z10 occupational hygiene requirements for potentially mutagenic nitroaromatics: solid handling restricted to ISO 5 laminar-flow booths with a face velocity of 0.45 m/s and a receptor-based exposure limit of 1 µg/m³ as an 8-hour TWA derived from the EMA Guideline on setting health-based exposure limits (EMA/CHMP/SWP/463259/2020) for genotoxic impurities in medicinal products. The final research output consists of a library plate containing 48–96 discrete analogues supplied to a screening biology team, and the identity and purity of each member are verified by orthogonal UPLC-UV-ELSD methods with a purity acceptance criterion of ≥ 95% at 254 nm.

    Cross-Sector Compliance and Process Parameter Matrix for 2-Chloro-5-Nitrothiazole-Derived Intermediates
    Downstream SectorPrimary Regulatory Framework / StandardCritical Impurity Limit / Process ParameterTypical Addition Ratio or Loading
    Pharmaceutical (nitazoxanide API)USP-NF 2024, ICH Q3A/Q3C, EMA/CHMP/SWP/463259/2020Dimeric nitrothiazole impurity ≤ 0.10%; Residual DCM ≤ 600 ppm2-Chloro-5-nitrothiazole : aq. NH₃ = 1:5 mole ratio initial charge
    Agrochemical (acaricide technical)FAO Specification 548/TC, CIPAC MT 184, EU 396/2005Residual Pd ≤ 20 ppm; Suspensibility ≥ 90%; D₉₀ ≤ 3 µmPd(PPh₃)₄ = 1.8 mol%; Boronic acid = 1.15 eq; Base = 2.5 eq
    Textile colorants (disperse dye)ZDHC MRSL Level 3, EN 14362-1:2017, AATCC 16.34-Chloroaniline release ≤ 30 ppm; Lightfastness ≥ Grade 4Dye on fabric: 0.5–3.0% o.w.f.; Coupling component excess 2%
    Organic photovoltaics (acceptor polymer)IEC 60904-1:2020, IEC 61215-2:2021 MQT 13Mₙ ≥ 35 kDa; Protodestannylated monomer content ≤ 0.3 mol%Donor:Acceptor polymer blend ratio = 1:1.2 (w/w); DIO = 0.5 vol%
    Discovery chemistry research librariesEMA CHMP health-based exposure limit, ANS Z10Occupational exposure limit ≤ 1 µg/m³ (8h TWA)Amine nucleophile: 1.2 eq per vial; Library aggregate mass ≤ 100 mg
    Free Quote

    Competitive 2-Chloro-5-Nitrothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    The compound crystallizes as pale‑yellow needles with a molecular weight of 178.57 g·mol⁻¹ (C₃HClN₂O₂S) and a melting endotherm onset at 52‑54 °C by differential scanning calorimetry (ASTM E794). Commercial-grade material established under ISO 9001:2015 quality management typically exhibits HPLC purity no lower than 98.5 % (area percent, detection at 254 nm, C18 column, acetonitrile/water mobile phase per USP <621>), with single‑impurity thresholds held below 0.5 %. Routine release data from multi‑ton campaigns at a dedicated fine‑chemicals site in Gujarat, operating glass‑lined reactors of 2 000 L nominal volume, confirm batch‑to‑batch assay drift of only ±0.2 % absolute when distillation cuts are taken under a vacuum of 10–15 mbar. The remaining specification envelope—summarized in Table 1—reflects the material’s role as a reactive heterocyclic intermediate destined for regulated pharmaceutical supply chains.
    Table 1 — Typical release specification for 2‑chloro‑5‑nitrothiazole (bulk)
    ParameterMethod / StandardLimit
    Assay (HPLC)In‑house SOP aligned to USP <621>≥ 98.5 %
    Melting rangeASTM E794‑06 (DSC, 5 K/min)52–55 °C
    Water contentKarl Fischer coulometry (ASTM D6304)≤ 0.5 %
    Residue on ignitionUSP <281>, 600 °C≤ 0.1 %
    Heavy metalsICP‑MS (ICH Q3D, oral PDE)Class 1 metals ≤ 2 ppm
    Chloride (as Cl⁻)AgNO₃ titration≤ 0.2 %
    Appearance of 10 % solution in acetoneVisual, against white backgroundClear, pale yellow

    What Distinguishes This Intermediate from 2‑Bromo‑5‑nitrothiazole in Scale‑Up Chemistry?

    The divergence between 2‑chloro‑5‑nitrothiazole and its 2‑bromo congener becomes operationally acute once a nucleophilic aromatic substitution (SNAr) sequence moves from discovery glassware to a 100 L glass‑lined vessel equipped with retreat‑curve impeller agitation. Under identical conditions—2.0 equiv benzylamine, 2.5 equiv anhydrous K₂CO₃, DMF at 80 °C—the chloro derivative exhibits a conversion half‑life (t₁/₂) of 48–55 min tracked by inline ReactIR monitoring of the nitro asymmetric stretch at 1 340 cm⁻¹. The equivalent bromo analogue reaches ≤3 % residual starting material within 12–15 min. While the faster leaving‑group kinetics of bromine may appear advantageous in a screening matrix, the accompanying heat‑release rate measured by reaction calorimetry (ASTM E537) frequently exceeds 180 W·kg⁻¹ during the first third of addition, pushing the instantaneous jacket setpoint to its limit. In a formal thermal safety assessment conducted on a 50 L HEL Simular, the adiabatic temperature rise (ΔTad) for the bromo substrate was calculated at 58 °C, versus 28 °C for the chloro compound, leaving a narrower safe operating envelope when processing the former at standard cooling‐coil utilities of 500 W·m⁻²·K⁻¹. A second discrimination arises from the genotoxic impurity (GTI) risk portfolio. Residual 2‑bromo‑5‑nitrothiazole readily undergoes metabolic debromination, and even at carry‑through levels of 50 ppm it triggers a positive Ames alert in TA 98 and TA 100 frameworks (OECD 471), necessitating a purge factor validation that complicates commercial API registrations. 2‑Chloro‑5‑nitrothiazole, by virtue of the stronger C–Cl bond (approximately 330 kJ·mol⁻¹ versus 280 kJ·mol⁻¹ for C–Br), decomposes to non‑mutagenic fragments under standard oxidative work‑up and shows clean AMP clean‑up factors exceeding 104 in silica‑gel plug flow‑through, verified by spiking‑and‑purge studies with LC‑MS detection down to 0.1 ppm. This property has made it the preferred electrophile in three recent ANDA filings for thiazolide‑class anthelmintics, where regulatory reviewers explicitly queried the absence of brominated impurities.
    Table 2 — Comparative reactivity and physical parameters of 2‑chloro‑5‑nitrothiazole and 2‑bromo‑5‑nitrothiazole
    Parameter2‑Chloro‑5‑nitrothiazole2‑Bromo‑5‑nitrothiazole
    Molecular weight178.57 g·mol⁻¹223.03 g·mol⁻¹
    Melting range (DSC)52‑54 °C63‑65 °C
    SNAr t₁/₂ (benzylamine, DMF, 80 °C)48–55 min8–12 min
    Adiabatic ΔTad (2 mol·L⁻¹, DMF)28 °C58 °C
    Ames outcome (OECD 471)Negative (≤1 250 µg/plate)Positive (TA 98, +S9)

    Critical Handling and Storage Parameters for Pilot‑Scale Operations

    Uncontrolled moisture ingress hydrolyzes the 2‑chloro substituent to the corresponding 5‑nitrothiazol‑2‑one, a degradation pathway that accelerates above 40 % relative humidity and is detectable as an additional HPLC peak at relative retention time 0.72. Warehousing practice adopted by two European distribution hubs relies on nitrogen‑blanketed, double‑bagged polyethylene containers within fiber drums stored at 2‑8 °C. Under those conditions, Karl Fischer titrational stability holds below 0.3 % for 24 months. Manufacturing campaigns that reintroduce drum‑heel material after exposure notice a small but consistent yield penalty of 3‑5 % in the subsequent amination step, traced to the thiazolone impurity acting as a weak nucleophile scavenger. The compound’s thermal sensitivity mandates that any drying operation conducted under vacuum not exceed a jacket temperature of 45 °C; a DSC ramp at 2 K·min⁻¹ reveals an onset of autocatalytic decomposition at 138 °C, evolving 1 200 J·g⁻¹. Contact with concentrated aqueous sodium hydroxide or neat primary amines at temperatures above 15 °C can trigger a rapid viscosity rise and precipitation of dark polymeric residues, a phenomenon reported on a 200 L line when a dosing line dead‑leg allowed static contact of neat substrate with a cleaning solution containing 5 % ammonia. Consequently, dedicated transfer lines with continuous solvent flushing are specified in the master batch record. Solubility in process‑typical solvents—acetone solvent (135 g·L⁻¹ at 20 °C), tetrahydrofuran (110 g·L⁻¹), and ethyl acetate (80 g·L⁻¹)—permits homogeneous charging without requiring a hot dissolution tank. When 2‑Chloro‑5‑nitrothiazole Replaces the Bromo Analogue in Late‑Stage Functionalization In the convergent synthesis of 2‑(arylthio)‑5‑nitrothiazole pharmacophores, the choice of halogen directly modulates the propensity for thiazole‑ring opening during thiolate displacement. Under conditions optimized for a 5‑trifluoromethyl‑2‑mercaptobenzimidazole coupling (K₂CO₃, NMP, 90 °C), the chloro substrate delivers the desired sulfide in 87 % isolated yield with <0.5 % ring‑opened by‑product, whereas the bromo analogue gives 73 % yield alongside 9 % of a ring‑fragmented impurity identified as the thiocyanate adduct by high‑resolution mass spectrometry. Larger‑scale demonstrations run in a 30 L Hastelloy C276 reactor at a Swiss contract manufacturing organization confirmed that the slower displacement rate of the chloride allows the equilibrium to steer away from the ring‑scission manifold, a selectivity advantage that cannot be replicated simply by lowering the reaction temperature. The disparity is equally pronounced when 2‑chloro‑5‑nitrothiazole is employed as a progenitor for 2‑hydrazinyl‑5‑nitrothiazole, a key synthon in numerous antiviral and antibacterial discovery programs. Condensation with hydrazine monohydrate in ethanol at 0‑5 °C proceeds with >95 % conversion within 2 h and minimal formation of the di‑substituted by‑product; analogous attempts with the bromo derivative demand cryogenic dosing at –20 °C and still produce a measurable 6‑8 % of the over‑addition impurity. For groups advancing SAR libraries around the 5‑nitrothiazole core, the chloro compound’s more gradual electrophilicity permits a wider temperature operating window—typically 0‑40 °C for secondary amines—without triggering runaway exotherms, which has been codified in internal process safety guidelines at one innovator after a 5 kg demonstration batch exhibited a 12 °C temperature overshoot when the bromo analogue was dosed into a piperidine solution at 25 °C. The nitro group’s powerful electron‑withdrawing effect (σp0.78) activates the 2‑position strongly enough that even the chloro leaving group permits completion of most coupling reactions in under 3 h, a timeline entirely compatible with standard shift‑based manufacturing cadences.